Active, not recruiting
Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors
NCT03044977
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Holden Comprehensive Cancer Center Iowa City, Iowa, United States